Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDuke Capital Regulatory News (DUKE)

Share Price Information for Duke Capital (DUKE)

Share Price is delayed by 15 minutes
Get Live Data
25.75    0.00 (0.00%)
Bid:
25.50
Ask:
26.00
Spread: 0.50 (1.961%)
Market Cap: £129.66m
DUKE Live PriceLast checked at - London Stock Exchange

Intraday Duke Capital Share Chart

New Royalty Partner

16 Feb 2021 07:00

RNS Number : 1749P
Duke Royalty Limited
16 February 2021
 

 

16 February 2021

 

Duke Royalty Limited

 

("Duke Royalty", "Duke" or the "Company")

 

New Royalty Agreement with a Leading UK Steel Fabrication Business

 

Duke Royalty, a provider of alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad, is pleased to announce that it has further diversified its revenue base by entering into a £6.2 million royalty financing agreement (the "Financing") with Meteor HoldCo Limited, which undertakes business as Fabrikat (Nottingham) Limited ("Fabrikat"). Formed in 1985 and based in Sutton-in-Ashfield, UK, Fabrikat is a fabricator of steel products supplying the UK street lighting and guardrail markets.

 

Highlights:

 

· Initial cash yield of approximately 14% per annum via monthly payments, which commence immediately

· 30-year secured financing, with distributions to be adjusted annually to reflect Fabrikat's consolidated revenue growth, on typical Duke terms

· Fabrikat has a long history of steady turnover and profitability, providing street lighting columns, guardrails and more bespoke products to local councils around the UK via contractors and Original Equipment Manufacturers ("OEMs")

· Duke's investment will facilitate a management buyout ("MBO") of two shareholders who, in recent years, have handed over the day to day running of the business to the current management team which has a combined tenure in the business of more than 60 years and lead all aspects of Fabrikat's operations

· As part of the recapitalisation, Duke will receive a 30% equity stake in the business

 

Neil Johnson, CEO of Duke Royalty, said:

 

"Fabrikat is a well-managed business with a longstanding track record of profitability, making it an ideal royalty partner for Duke. The business' long history of growing market share and its ability to withstand and successfully navigate challenging environments, including the recent turbulence created by the pandemic, makes us confident of the Company's short and long-term future prospects. Our support of this MBO reflects our confidence in the management team's ability to continue the success achieved to date and illustrates how effective our capital is in MBO situations.

 

"Additionally, with Duke's existing credit facility with Pollen Street Capital, we are well positioned to make more investments in the coming months as we focus on capitalising on the increasing demand for long term, flexible sources of finance."

 

Paul Allen, CFO of Fabrikat, said:

 

"Duke's investment solution has been a great fit for this transaction. By taking on Duke's capital, the other members of the MBO team and I can assume operational control and a majority equity shareholding in a company where we have worked for most of our careers. We are excited to take Fabrikat forward and build on the excellent reputation of the firm."

 

Further information regarding Fabrikat

Fabrikat was founded in 1985 and is now the largest independently owned manufacturer of lighting columns and guardrails in the UK. Fabrikat designs, manufactures and supplies street lighting columns, traffic management and telecommunication structures, pedestrian guardrail, parapet, fencing and street furniture products. Leveraging its decades of experience and expertise in manufacturing and engineering, it has broadened its offering to include column testing, evaluation and asset management services.

Fabrikat has a diverse and expanding customer base, supplying local authorities, contractors, developers, specifiers, wholesalers, and lighting OEMs. Increasingly it is pivoting into higher margin, bespoke sub-sectors.

Two members of the MBO Team have been at the company for more than 30 years and across the management team there is deep technical expertise in the steel fabrication market. The company is based in Sutton-in-Ashfield, UK and employs c.80 staff across its production and administrative functions.

About the Financing

 

Duke has committed £6.2 million of capital to enable the current management team to shape the future growth and build on the stable foundations of a long-standing, profitable business. Importantly, there will be no change to the day-to-day management of Fabrikat.

 

The terms of the Financing are in line with Duke's typical investment criteria. The Financing is provided through a combination of a secured loan and preference shares and Duke will be entitled to monthly distributions (the "Distribution") beginning in March 2021.

 

In line with Duke's other investments, and reflective of the participating nature of Duke's business model, the Distribution will be adjusted annually based on the percentage change in total combined gross revenues of the Group for the 12 months to 31 December 2021, compared to the prior financial (calendar) year. The first adjustment will occur from March 2022. The annual adjustment in the Distribution will be subject to an agreed collar.

 

The Financing is for a period of 30 years, with the Distribution payable to Duke throughout the duration of this term, unless Fabrikat utilises an early buyback option which will trigger an early redemption payment to Duke. In addition, Duke has received 30% of the fully diluted ordinary equity of the Group as part of its investment.

Duke Royalty Portfolio

A full list of Duke's current Royalty Partners are now included for reference on our Partners page of our website: www.dukeroyalty.com/partners

 

 

***ENDS***

 

For further information, please visit www.dukeroyalty.com or contact:

 

Duke Royalty Limited

Neil Johnson / Charlie Cannon Brookes / Hugo Evans

 

 

+44 (0) 1481 741 240

Cenkos Securities plc 

(Nominated Adviser

and Joint Broker)

 

Stephen Keys / Callum Davidson / Julian Morse / Michael Johnson

 

+44 (0) 207 397 8900

 

Canaccord Genuity

(Joint Broker)

 

Adam James / Georgina McCooke

+44 (0) 207 523 8000

SEC Newgate (PR)

Elisabeth Cowell/ Tom Carnegie/ Megan Kovach

+ +44 (0) 20 3757 6880 dukeroyalty@secnewgate.co.uk

 

About Duke Royalty

 

Duke Royalty Limited provides alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad. Duke Royalty's experienced team provide financing solutions to private companies that are in need of capital but whose owners wish to maintain equity control of their business. Duke Royalty's royalty investments are intended to provide robust, stable, long term returns to its shareholders. Duke Royalty is listed on the AIM market under the ticker DUKE and is headquartered in Guernsey.

 

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon publication of this announcement, this inside information is now considered to be in the public domain.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGREAXASFSKFEFA
Date   Source Headline
10th May 20225:08 pmRNSPrimaryBid Offer
10th May 20224:44 pmRNSPlacing to raise a minimum of £15 million
28th Apr 20227:00 amRNSFollow-On Investment into Existing Royalty Partner
20th Apr 20227:00 amRNSFollow-On Investment into Existing Royalty Partner
11th Apr 20227:00 amRNSTrading Update
18th Mar 20227:00 amRNSFollow-On Investment into Existing Royalty Partner
17th Mar 20227:00 amRNSIncreased Interim Dividend & Dividend Declaration
2nd Mar 20227:00 amRNSFollow-On Investment into Existing Royalty Partner
25th Feb 20227:00 amRNSFollow-On Investment into Existing Royalty Partner
17th Feb 20227:00 amRNSFurther re: Directorate Change
14th Feb 20227:00 amRNSFollow-On Investment into Existing Royalty Partner
2nd Feb 20227:00 amRNSDirectorate Changes
1st Feb 202210:02 amRNSReplacement - Trading Update
1st Feb 20227:00 amRNSTrading Update
20th Jan 20227:00 amRNSFollow-On Investment into Existing Royalty Partner
23rd Dec 20212:30 pmRNSHolding(s) in Company
23rd Dec 20217:01 amRNSTrading Update
23rd Dec 20217:00 amRNSFollow-on investment into existing Royalty Partner
22nd Dec 20213:52 pmRNSFollow-on investment into existing Royalty Partner
16th Dec 20217:00 amRNSNew Royalty Agreement
14th Dec 20217:00 amRNSIncreased Interim Dividend & Dividend Declaration
7th Dec 20217:00 amRNSEnters into Largest Royalty Agreement To Date
3rd Dec 20217:00 amRNSInterim Results
2nd Dec 20217:00 amRNSCompletion of £4.2 million Follow-On Investment
25th Nov 20217:00 amRNSNotice of Interim Results
29th Oct 20214:03 pmRNSLong Term Incentive Plan Awards
27th Oct 20217:01 amRNSFollow-On Investment into Existing Royalty Partner
27th Oct 20217:00 amRNSHolding(s) in Company
22nd Oct 20214:36 pmRNSResult of Annual General Meeting
16th Sep 20217:01 amRNSInterim Dividend and Dividend Declaration
16th Sep 20217:00 amRNSFinal Results
7th Sep 20217:00 amRNS£2.2m Follow-On Investment into Royalty Partner
2nd Sep 20217:00 amRNSHolding(s) in Company
17th Aug 20217:00 amRNSInvestor Presentation
11th Aug 20217:00 amRNSSuccessful Exit of Investment in Royalty Partner
10th Aug 20217:00 amRNSNotice of Results and Analyst Presentation
2nd Aug 20217:00 amRNSNew Royalty Agreement
26th Jul 20217:00 amRNSTrading Update
22nd Jul 20217:00 amRNSNew Royalty Agreement
1st Jul 20217:00 amRNSNew Royalty Agreement with Fairmed Healthcare AG
17th Jun 20217:00 amRNSInterim Dividend and Dividend Declaration
10th May 20217:00 amRNSTrading Update
20th Apr 20215:22 pmRNSHolding(s) in Company
20th Apr 20215:19 pmRNSHolding(s) in Company
20th Apr 20214:19 pmRNSHolding(s) in Company
19th Apr 202112:30 pmRNSDirector / PCA Dealings
19th Apr 20217:00 amRNSSuccessful Exit of Investment in Royalty Partner
16th Apr 20213:14 pmRNSResult of General Meeting and Issue of Equity
6th Apr 20215:17 pmRNSResult of PrimaryBid Offer and Total Voting Rights
1st Apr 20217:00 amRNSResult of Placing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.